In 2024, Mission Cancer + Blood joined forces with University of Iowa Health Care to create a statewide network of cancer ...
The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.